Advanced searches left 3/3

Augmentin - Crossref

Summarized by Plex Scholar
Last Updated: 03 May 2022

* If you want to update the article please login/register

Effects of Following National Committee for Clinical Laboratory Standards and Deutsche Industrie Norm-Medizinische Mikrobiologie Guidelines, Country of Isolate Origin, and Site of Infection on Susceptibility of Escherichia coli to Amoxicillin-Clavulanate (Augmentin)

Hence, reported differences in amoxicillin-clavulanate percent susceptibilities among Escherichia coli isolates may have localized resistance issues and/or methodological variations in susceptibility testing and breakpoint criteria. Different amounts of amoxicillin-clavulanate MICs were found in different strains than those obtained with the DIN method, which was highlighted by the 10% more strains' results being within the 8- to 32-gram/ml MIC range. Both NCCLS and DIN methodologies also produce different MIC profiles for cefotaxime, but not for cefuroxime. According to the NCCLS methods, 86. 5% strains were discovered to be amoxicillin-clavulanate, although only 43. 8 percent were found to be vulnerable by the DIN method. The use of DIN breakpoints resulted in a fivefold higher incidence of strains classified as cefuroxime-resistant strains. Isolates from urinary tract and intra-abdominal infections were usually more resistant to amoxicillin-clavulanate than were isolates from other sources of infection.

Source link: https://doi.org/10.1128/jcm.36.5.1361-1365.1998


In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits

In vitro, Augmentin, a combination drug made of two parts amoxicillin and one part clavulanic acid and a potent beta-lactamase inhibitor, was tested in vitro against selected clinical isolates for its inhibitory and bactericidal activities against selected clinical isolates. To establish tentative quality control limits, a multicenter performance investigation of the disk diffusion test was conducted with three quality control agencies to determine tentative quality control limits. Both methicillin-susceptible staphylococci and Haemophilus influenzae isolates were susceptible to Augmentin, but the minimal inhibitory concentrations for beta-lactamase-producing strains of both species were fourfold higher than those for enzyme-negative strains. Augmentin, a bacteria that causes ampicillin resistance against Klebsiella pneumoniae, Citrobacter diversus, Proteus vulgaris, and approximately one-third of the Escherichia coli strains tested were all higher than did ampicillin against Klebsiella pneumoniae, Probsiella vulgaris, Prosiella vulgaris.

Source link: https://doi.org/10.1128/aac.24.1.31


Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography

Augmentin is a new antibacterial drug formulation that is composed of amoxicillin and the beta-lactamase inhibitor clavulanic acid. The use of high-performance liquid chromatography in the present paper is described as a quick measure of Augmentin's components in body fluids. Both human serum and urine contain interfering substances. This derivative chromatographs on reverse-phase HPLC columns are free of interfering components. With this method, clavulanic acid concentrations as low as 0. 1 microgram/ml were readily detectable in human serum. HPLC without derivatization detected Amoxicillin in body fluids directly. An alkali blanking procedure for amoxicillin and clavulanic acid has also been described, enabling the detection of any underlying peaks that may cochromatograph. The synthesis of clavulanic acid and amoxicillin was carried out with ultrafiltration to remove protein from serum samples prior to HPLC.

Source link: https://doi.org/10.1128/aac.22.5.753


Comparative Treatment Trial of Augmentin Versus Cefaclor for Acute Otitis Media with Effusion

A total of 150 children with acute otitis media were randomly assigned to amoxicillin-potassium clavulanate or cefaclor therapy. In 67% of cases, Tympanocentesis was performed before diagnosis and produced pneumococcus, Haemophilus sp or both in 67% of specimens. Steptococci were isolated from 10% of samples and Branhamella catarrhalis from 6% of patients. Both Diaper rash, or loose stools in children treated with Augmentin were significantly more prevalent in children treated with Augmentin than in cefaclor treated with cefaclor, but in no case was it necessary to stop taking drugs due to these minor side effects. In the acute phase of acute otitis media with effusion, treatment with cefaclor was more effective than cefaclor therapy, but Augmentin had more adverse effects. Both conditions were similar to those in previous middle ear efusion and recurrent acute otitis media with effusion.

Source link: https://doi.org/10.1542/peds.75.5.819


The application of augmentin for prophylaxis of pyo-septical complications after caesarean section

During a surgical procedure and on the first day after a surgical intervention was made, the comparison results on prophylactic effectiveness of Cefalosporins and Augmentin infused during a surgical procedure and Augmentin infused during a surgical procedure and during the first day after a surgical treatment was made.

Source link: https://doi.org/10.17816/jowd87957


Metronidazole and Augmentin in the prevention of sepsis after appendicectomy

Abstract Two hundred and fifty patients were accepted to a prospective controlled trial to determine the effectiveness of Augmentin with metronidazole in the prevention of sepsis after appendicectomy. Wound infection in the gangrenous group, especially in the persecutive group, was at a high risk. While there was no statistically significant difference between the two antibiotics' infection rates, our analysis shows that Augmentin, which is active against both aerobes and anaerobes, is more effective than metronidazole in reducing wound sepsis after appendicectomy.

Source link: https://doi.org/10.1002/bjs.1800720724


Augmentin in Acute Exacerbations of Chronic Bronchitis

Augmentin, a benzycillin mixed with the clavulanic acid, was used by parents with acute chronic respiratory bronchitis firstly by parenteral administration followed by oral therapy after 3 days. Augmentin's parenteral formulation seems to be a helpful supplement to lower respiratory tract infections therapy for children.

Source link: https://doi.org/10.1177/030006058401200601


Further Experience with Augmentin in the Treatment of Skin Infections

Patients with skin infections were treated with Augmentin, a combination of amoxycillin and the clavulanic acid clavulanic acid. Patients responded to therapy with only one withdrawal. There was no evidence of Clostridium difficile toxin production in the stools by a patient with diarrhoea. Augmentin appears to be a safe, effective, and inexpensive antibiotic for the treatment of skin infections in general practice and hospital.

Source link: https://doi.org/10.1177/00369330820270s108


Augmentin (Amoxycillin and Clavulanic Acid) in the Treatment of Urinary Tract Infections

Amoxycillin's potentiation by the clavulanic acid reduces the amount of resistance in most Gram-negative urinary pathogens, and these organisms are also sensitive to urinary amoxycillin levels that are not present in a normal dosage. Augmentin in a dose of 375 mg tds is well tolerated, and no adverse gastrological side effects have been reported.

Source link: https://doi.org/10.1177/00369330820270s107


Respiratory Tract Infections Caused by ß-Lactamase Producing Organisms Treated with Augmentin

Patients were hospitalized with acute respiratory tract infections caused by -lactamase producing organisms in Augmentin. The four deaths were traced to three non-lactamase-producing H. influenzae, as well as three mixed organisms, including Staph autarus. Augmentin is a useful drug in the treatment of respiratory tract disease, particularly in acute exacerbation of chronic bronchitis.

Source link: https://doi.org/10.1177/00369330820270s106

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions